Navigation Links
Rare Disease Therapeutics, Inc. Selects Accredo Health Group to Distribute Anascorp® for the Treatment of Centruroides Scorpion Sting Envenomation
Date:9/13/2011

FRANKLIN LAKES, N.J. and MEMPHIS, Tenn., Sept. 13, 2011 /PRNewswire/ -- Rare Disease Therapeutics, Inc. (RDT) announced today that its recently approved Anascorp® (Centruroides (Scorpion) Immune F(ab')2 (Equine) Injection) is now available on the market through Accredo Health Group, Inc. – a wholly owned subsidiary of Medco Health Solutions, Inc. (NYSE: MHS).  On August 3, 2011, Anascorp became the first treatment approved by the United States Food and Drug Administration (FDA) for Centruroides scorpion sting envenomation, and has been awarded orphan drug designation by the FDA, providing a seven-year period of market exclusivity.  Accredo is the sole U.S. specialty distributor of the medication.

(Logo:  http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO)

"Accredo's experience successfully managing the nuances associated with products targeting rare diseases for small patient populations makes pharmaceutical manufacturers, such as Rare Disease Therapeutics, Inc., confident in trusting their product launch to our team," said Accredo President, Frank Sheehy.  "We look forward to working with Rare Disease Therapeutics, Inc. to deliver this important medication to those in need."

Accredo will offer specialty wholesale distribution services of Anascorp to hospitals and other appropriately licensed facilities.

"Rare Disease Therapeutics, Inc. has worked with Accredo for nearly ten years to provide patients with access to our potential life-saving medications for rare diseases," said Rare Disease Therapeutics, Inc. President Milton H. Ellis. "We worked successfully with Accredo to distribute Anascorp during the clinical trial phase, and we are excited to expand our relationship now that Anascorp is available commercially."

To obtain more information call 1-866-830-7437.

About Anascorp®

<
'/>"/>

SOURCE Medco Health Solutions, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. HemaQuest Pharmaceuticals Completes Patient Enrollment in Phase 2 Clinical Study of HQK-1001 in Patients With Sickle Cell Disease
2. Curemark Issued Patent for the Diagnosis of Parkinsons Disease
3. Regulus Therapeutics to Present New Advancements in microRNA Therapeutics for Treatment of Metabolic Diseases and Cancer
4. Anadys Setrobuvir Named One of Windhovers Top 10 Most Interesting Infectious Disease Projects to Watch
5. Galenea and CHDI Foundation Announce Collaboration to Identify Key Synaptic Dysfunction in Huntingtons Disease
6. Californians Recognized For Role In Helping Rare Disease Patients Who Need Lifesaving Therapies
7. Floridians Recognized for Role in Helping Rare Disease Patients Who Need Lifesaving Therapies
8. Californians and Floridians Recognized for Role in Helping Rare Disease Patients Who Need Lifesaving Therapies
9. Better Funding for Research into Blood Diseases Will Save More Lives
10. Alzheimers Drug Discovery Foundation Supports Madera Biosciences with a Grant to Advance Novel Drug Candidates for Alzheimers Disease
11. IRS Proposed Regulations on Orphan Drug Exclusion from Drug Tax Stand to Harm Future Development of Treatments for Rare Disease Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... July 22, 2014 Cumberland Pharmaceuticals Inc. (NASDAQ: ... 2014 financial results after the market closes on Tuesday, ... webcast will be held on Tuesday, August 5, 2014, ... To participate in the call, please dial ... A rebroadcast of the teleconference will be available for ...
(Date:7/22/2014)... 22, 2014 The National Space Biomedical Research ... for Space Radiation Research (CSRR) under the leadership of ... Associate Professor of Pharmaceutical Sciences within the University of ... of Radiation Health. She is located in ... team of investigators working across four U.S. institutions, to ...
(Date:7/22/2014)... Resources Group finds that the market for interventional cardiology (IC) ... stagnant at a value of around $80 million through 2022. ... volumes are growing faster in Canada ... United States and Europe . ... penetration of PCI procedures relative to coronary artery bypass graft ...
Breaking Medicine Technology:Cumberland Pharmaceuticals To Announce Second Quarter 2014 Financial Results On August 5, 2014 2Boerma Led UAMS Team to Establish NSBRI's Center for Space Radiation Research (CSRR) 2Boerma Led UAMS Team to Establish NSBRI's Center for Space Radiation Research (CSRR) 3The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million 2The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million 3
... Meghan Lopresto, VP, Sales Force Automation Analytics at The ... Vaccines, will be co-presenting their expertise in interactive selling ... in Philadelphia. The conference is a ... and medical affairs professionals to discuss novel approaches to ...
... -- In 2012, Fi Asia-China, Hi & Ni ... food & beverage shows in China, will take ... Shanghai New International Expo Centre (SNIEC), organized by ... ) (Logo: http://www.prnasia.com/sa/2010/04/19/20100419602891.jpg ) ...
Cached Medicine Technology:The CementBloc and Novartis Vaccines to Jointly Present Top Considerations in Interactive Selling at the 11th Annual iPharmaConnect 2Fi Asia-China, Hi & Ni China is Ready for Return on June 2012 in Shanghai 2
(Date:7/22/2014)... CA (PRWEB) July 22, 2014 The ... to increase in size through 2022, according to new ... improve their appearance can benefit from a new guide ... review for women is now available at http://cherrynews.com/best-nourishing-eye-serum ... and includes instant links to many of the top ...
(Date:7/22/2014)... Campbell, CA (PRWEB) July 22, 2014 ... along with his surgical colleagues, have recently discussed the ... implants. Many leaders in the periodontics profession are seeing ... implants go up exponentially. In fact, one surgeon reported ... treat failing implants. Although dental implants have a very ...
(Date:7/22/2014)... Steven Reinberg HealthDay Reporter ... treatments that break up blood clots deep in the veins ... risk. However, one results in a greater risk of bleeding ... of the other treatment, a new study finds. The ... thrombosis (DVT) -- is blood-thinning medications and compression stockings. The ...
(Date:7/22/2014)... Club you eat pretty much everything you put on ... University study shows that the average adult eats 92% of ... plate. "If you put it on your plate, it,s ... the forthcoming book, Slim by Design, Professor of Marketing and ... and co-author Katherine Abowd Johnson analyzed 1179 diners and concluded ...
(Date:7/22/2014)... 22, 2014 As reported on July 17, ... request to name her favorite beauty products, “ Botox , ... say that “ Botox has changed my life” by ... chair preparing for her various, daily appearances. “Suddenly my ... Ripa (see: goo.gl/shmTQM). , “I think that Kelly Ripa’s response ...
Breaking Medicine News(10 mins):Health News:Eye Serum Review for Women: New Guide Published Online by Top Review Website 2Health News:Dr. Jeremy Ueno Can Help Treat Patients That Have Failing Implants 2Health News:Dr. Jeremy Ueno Can Help Treat Patients That Have Failing Implants 3Health News:Study Casts Doubt on Costly Treatment for Leg Clots 2Health News:Study Casts Doubt on Costly Treatment for Leg Clots 3Health News:Celebrity Botox: Kelly Ripa Confesses to Getting Botox Injections 2
... Public Health have found the first evidence that perfluorinated ... in everyday items such as food packaging, pesticides, clothing, ... associated with infertility in women. , ... reproductive medicine journal, the study found that women who ...
... Omaha-based SimplyWell will be presented to President ... health care in the United States.Former Speaker of the House ... hosted a special event January 26 at the National Press ... of Finding What Works." Joined by a ...
... 30 Meijer initiated a voluntary,recall of two types of ... ice cream novelties sold in all of its stores in ... from,its stores and gas stations. All sell-by dates are impacted ... has recalled the following items:, -- Meijer ...
... sugary fare may be to blame, researchers say , , ... TV more than five hours a day are prone ... suggests. , The connection? Too much time spent watching ... food choices, University of Minnesota researchers say. , "Television ...
... Jan. 30 Turner Construction Company, the nation,s ... the $323 million state-of-the-art Greenfield replacement hospital for ... manager for the project that is scheduled for ... advanced technologies in order to ensure quality clinical ...
... the American Heart Association recommends that omega-6 polyunsaturated fatty ... seeds, are beneficial when part of a heart-healthy eating ... energy (calories) from omega-6 PUFAs, and will derive most ... in the diet. Precise recommended daily servings will depend ...
Cached Medicine News:Health News:Household chemicals may be linked to infertility 2Health News:Household chemicals may be linked to infertility 3Health News:Applying the Obama Test to Healthcare: SimplyWell Cited as Top 10 Best Practices by Center for Healthcare Transformation 2Health News:Meijer Announces Voluntary Recall for Some Meijer Brand Peanuts and Ice Cream Novelties Citing Possible Health Risk 2Health News:Adult Fast-Food Diets Tied to Too Much TV as Teen 2Health News:Adult Fast-Food Diets Tied to Too Much TV as Teen 3Health News:Turner Reaches Milestone on $323 Million Virtua West Jersey Replacement Hospital in Voorhees, N.J. 2Health News:Omega-6 PUFAs and risk of cardiovascular disease 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: